ArticleCancer control : journal of the Moffitt Cancer Center

Real-World Outcomes With Inetetamab-Based Regimens for HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Analysis in China.

Fangchao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.